Nigerian Pharma Stocks Soar Over 100% Led by Fidson Healthcare
Nigerian pharmaceutical stocks, including Fidson Healthcare, Neimeth International, May & Baker Nigeria, and Mercur Industries, have surged over 100% in 9 months on the Nigerian Exchange. Fidson reported a 181% rise in stock price, driven by a 68% revenue increase and nearly 300% jump in profit.
The market rally reflects investor confidence in the sector's growth potential amid a positive economic environment and government measures to boost local production.
Plus234Feed summary based on reporting from Business Day. Read the original report below.
Read full article
Continue on Business Day
Share
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Free · one email per week · unsubscribe anytime
Related Stories
Business
Nigerian Health Stocks Surge on Investor Confidence in Pharma Growth
Health
Fidson, Ohara Pharmaceutical Partner to Boost African Healthcare
Business
Nigerian Stock Market Surges as Beta Glass and Insurers Lead Rally
Business
Nigerian Stock Market Gains Momentum, Key Sectors Drive Growth
Business
Nigerian Exchange NGX Sees 0.50% ASI Rise and Trillion Naira Market Cap Surge
Business
Nigerian Stock Market Gains, Providus Bank to Rebrand After Merger
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
